First-line chemotherapy with planned sequential administration of gemcitabine (G) followed by docetaxel (D) in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study

Enrico Vasile,C. Tibaldi,A. Antonuzzo,R. Di Marsico,G. Tartarelli,A. Fabbri,M. Lo Dico,E. Mazzoni,M. Andreuccetti,Alfredo Falcone

First-line chemotherapy with planned sequential administration of gemcitabine (G) followed by docetaxel (D) in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study

2008

Enrico Vasile
C. Tibaldi
A. Antonuzzo
R. Di Marsico
G. Tartarelli
A. Fabbri
M. Lo Dico
E. Mazzoni
M. Andreuccetti
Alfredo Falcone

19092 Background: Single-agent chemotherapy (G or vinorelbine) is currently a standard treatment for elderly advanced NSCLC patients. The combination of G+D was active but not well tolerated in thi...

Keywords:

Physical therapy
non-small cell lung cancer (NSCLC)
Gemcitabine
Phases of clinical research
Cancer research
Chemotherapy
Oncology
Internal medicine
Medicine
Docetaxel
first line chemotherapy
Vinorelbine
Standard treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations